ArticleGene therapy2017
Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I.
L Bočkor et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it